By Sally Robertson, B.Sc. Apr 28 2021 Researchers in the UK and United States have demonstrated the efficacy of one dose of either the Pfizer-BioNTech or Oxford-AstraZeneca vaccine against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a real-world community setting in the UK. The novel SARS-CoV-2 virus is the agent responsible for the coronavirus...
Standard drugs remain the best first-line treatments for epilepsy, according to the results of two UK clinical trials led by the University of Liverpool. The Standard and New Antiepileptic Drugs (SANAD II) studies compared a range of antiepileptic drugs for how well they control seizures, their general tolerability and their cost, to assess whether newer drugs should...
A new approach to treating one of the leading causes of blindness among patients with diabetes is being tested in clinical trials which begin this month. The trial involves 48 patient volunteers with diabetic macular oedema (DMO), a disease where blood vessels leak fluid into the retina. It is the most common cause of vision...
By Rich Haridy August 19, 2020 A new study is questioning whether potential Alzheimer’s treatments previously found to be ineffective in human trials should be re-examined, after the discovery of a specific gene that can inhibit a therapy’s efficacy is only present in 75 percent of people. The long-standing cholinergic hypothesis for Alzheimer’s disease suggests...
By Sally Robertson, B.Sc. Researchers at the University of California San Diego have conducted a study showing that both smoking and the use of e-cigarettes containing nicotine and flavorings may critically exacerbate inflammation in cases of coronavirus disease 2019 (COVID-19) and significantly worsen clinical outcomes. The use of e-cigs that do not contain nicotine or...
by From Mayo Clinic News Network, Mayo Clinic News Network Mayo Clinic researchers have defined a form of Alzheimer’s disease that strikes younger people as early as their 40s, presents with atypical symptoms, and affects a different part of the brain not usually associated with Alzheimer’s. In their study, the researchers describe a progressive dysexecutive...
by Bob Yirka , Medical Xpress A team of researchers with members affiliated with a large number of institutions in Korea, two in the U.S. and one in the U.K. has released data from the initial phase of the Korean Genome Project (Korea1K). In their paper published in the journal Science Advances, the group notes...
Falls have serious consequences for seniors, especially those who live alone. Medical alert devices can notify emergency services, but they are not always worn. In addition, they do not address fall prevention by encouraging active lifestyles and physical strengthening. WalkWise hopes to fill these gaps. The Fargo, ND-based company offers a smart device that can...
by University of Utah Health Sciences In her Genomic Signal Processing Lab, Alter develops new mathematical methods that are uniquely suited for personalized medicine. Credit: Nathan L. Galli, University of Utah For the past 70 years, the best indicator of life expectancy for a patient with glioblastoma (GBM)—the most common and the most aggressive brain...
The handheld device weighs in at 5.5 pounds (2.5 Kg) and resembles a large digital camera with a touchscreen. AiRTouch acquires images with the push of a button and can wirelessly transmit them to PACS (clinical image storage system), without the need for a computer. Its battery charges within two hours and can capture up...
